Lincoln Pharmaceuticals Ltd (LINCOLN) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 294056, "name": "Lincoln Pharma.", "stock_name": "Lincoln Pharma.", "full_name": "Lincoln Pharmaceuticals Ltd", "name_url": "stocks-analysis/lincoln-pharma", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "635.05", "chg": 5.7, "chgp": "0.91%", "dir": 1, "prev_price": "629.35", "mcapval": "1,284.00 Cr", "mcap": "Micro Cap", "scripcode": 531633, "symbol": "LINCOLN", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE405C01035", "curr_date": "Jun 12, 03:30 PM", "curr_time": "10:48 AM", "last_traded_at": "Jun 12, 03:30 PM IST", "bse_nse_vol": "48.99 k", "exc_status": "Active", "traded_date": "Jun 12, 2026", "traded_date_str": "2026 06 12", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/lincoln-pharma-294056-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Lincoln Pharmaceuticals Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/lincoln-pharmaceuticals-ltd-is-rated-hold-4051058", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/LincolnPharmace_mojoScore_4051058.png", "date": "2026-06-13 10:10:05", "description": "Lincoln Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 16 March 2026. While this rating change occurred in March, the analysis and financial metrics presented here reflect the stock's current position as of 13 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Lincoln Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicator Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4045774", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/LincolnPharmace_technicaldot_4045774.png", "date": "2026-06-11 08:01:19", "description": "Lincoln Pharmaceuticals Ltd has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish trend as of mid-2026. While key indicators such as the MACD and Bollinger Bands maintain positive signals on weekly and monthly timeframes, divergences in RSI and KST readings suggest a complex outlook for investors navigating this micro-cap pharmaceutical stock." }, { "title": "Lincoln Pharmaceuticals Ltd Technical Momentum Shifts Signal Bullish Outlook", "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-ltd-technical-momentum-shifts-signal-bullish-outlook-4043202", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/LincolnPharmace_technicaldot_4043202.png", "date": "2026-06-10 08:01:28", "description": "Lincoln Pharmaceuticals Ltd has demonstrated a notable shift in price momentum, supported by a series of bullish technical indicators that have upgraded its outlook from a previous sell rating to a hold. With a current market price of ₹637.35, the micro-cap pharmaceutical stock is showing signs of renewed strength, outperforming the broader Sensex over multiple time horizons." }, { "title": "Lincoln Pharmaceuticals Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/lincoln-pharmaceuticals-ltd-is-rated-hold-4030683", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/LincolnPharmace_mojoScore_4030683.png", "date": "2026-06-02 10:10:03", "description": "Lincoln Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 16 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 June 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Lincoln Pharmaceuticals Ltd: Valuation Shifts Signal Renewed Price Attractiveness", "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-ltd-valuation-shifts-signal-renewed-price-attractiveness-4029101", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/LincolnPharmace_valuationdot_4029101.png", "date": "2026-06-02 08:01:08", "description": "Lincoln Pharmaceuticals Ltd has seen a notable shift in its valuation parameters, moving from a fair to an attractive rating, driven by improved price-to-earnings and price-to-book ratios relative to its historical averages and peer group. Despite a recent dip in share price, the company’s fundamentals and relative valuation metrics suggest a more compelling investment case within the Pharmaceuticals & Biotechnology sector." }, { "title": "Lincoln Pharmaceuticals Ltd Technical Momentum Shifts Amid Market Volatility", "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-ltd-technical-momentum-shifts-amid-market-volatility-4025002", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/LincolnPharmace_technicaldot_4025002.png", "date": "2026-06-01 08:00:52", "description": "Lincoln Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a bullish to a mildly bullish trend as of early June 2026. Despite a significant day decline of 16.67%, the stock’s longer-term technical indicators present a complex picture, with bullish signals on weekly and monthly MACD and OBV, contrasted by bearish monthly RSI and KST readings. This nuanced technical landscape warrants a detailed analysis for investors seeking clarity on the stock’s near-term trajectory within the Pharmaceuticals & Biotechnology sector." }, { "title": "Lincoln Pharmaceuticals Drops 13.84%: 3 Key Events Shaping the Week", "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-drops-1384-3-key-events-shaping-the-week-4024180", "imagepath": "", "date": "2026-05-31 10:01:54", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>May 25:</strong> Stock falls 2.21% to Rs.717.20 amid broad market gains</p>\n <p><strong>May 26:</strong> New 52-week high near Rs.749.45, closing at Rs.745.25 (+3.91%)</p>\n <p><strong>May 27:</strong> All-time high reached at Rs.770 intraday, closing Rs.758.35 (+1.76%)</p>\n <p><strong>May 29:</strong> Sharp decline of 16.67% to Rs.631.90 following Q4 FY26 results</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.733.40</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Wee..." }, { "title": "Lincoln Pharmaceuticals Q4 FY26: Profit Stagnates Amid Margin Compression and Volatile Other Income", "link": "https://www.marketsmojo.com/news/result-analysis/lincoln-pharmaceuticals-q4-fy26-profit-stagnates-amid-margin-compression-and-volatile-other-income-4022046", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/LincolnPharmace_quaterlyResult_4022046.png", "date": "2026-05-29 10:04:22", "description": "Lincoln Pharmaceuticals Ltd., the Ahmedabad-based pharmaceutical formulations manufacturer, reported a marginal 0.43% year-on-year increase in net profit to ₹11.63 crores for Q4 FY26, barely surpassing the ₹11.58 crores posted in Q4 FY25. The muted earnings growth came despite an 11.36% rise in net sales to ₹187.28 crores, as the company grappled with contracting operating margins and a significant negative swing in other income. The stock plummeted 10.73% on May 29, 2026, closing at ₹677.00, reflecting investor disappointment with the lacklustre quarterly performance from a company valued at ₹1,356 crores." }, { "title": "Broad-Based Technical Strength Lifts Lincoln Pharmaceuticals Ltd to 52-Week High of Rs 770", "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-ltd-hits-new-52-week-high-at-rs770-4016224", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/LincolnPharmace_priceRelatedfactors_4016224.png", "date": "2026-05-27 09:49:57", "description": "Surging to a fresh 52-week high of Rs 770 on 27 May 2026, Lincoln Pharmaceuticals Ltd has demonstrated robust price momentum, outperforming its sector and the broader market with a 37.3% gain over the past year against the Sensex’s decline of 6.9%." } ], "total": 989, "sid": "294056", "stock_news_url": "https://www.marketsmojo.com/news/lincoln-pharmaceuticals-294056" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "29-May-2026", "details": "We enclosed herewith the copies of published newspaper advertisement with respect to Audited (Standalone & Consolidated) Financial Results of the Company for the Quarter and Year ended March 31 2026.", "source": "BSE" }, { "caption": "Audited Financial Results For The Quarter And Year Ended 31St March 2026", "datetime": "28-May-2026", "details": "Audited Financial Results for the Quarter and Year ended March 31 2026.", "source": "BSE" }, { "caption": "Corporate Action-Board approves Dividend", "datetime": "28-May-2026", "details": "Recommended a Final Dividend of Rs. 1.80/- (i.e 18%) per equity share of face value Rs. 10/- each for the financial year ended March 31 2026 subject to approval of the members at the ensuing Annual General Meeting of the Company.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Lincoln Pharmaceuticals Ltd has declared <strong>18%</strong> dividend, ex-date: 12 Sep 25", "dt": "2025-09-12", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "", "data": [ { "txt": "Lincoln Pharmaceuticals Ltd has announced <strong>10:2</strong> stock split, ex-date: 19 Mar 09", "dt": "2009-03-19", "middle_text": "Split" } ] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

May 25: Stock falls 2.21% to Rs.717.20 amid broad market gains

May 26: New 52-week high near Rs.749.45, closing at Rs.745.25 (+3.91%)

May 27: All-time high reached at Rs.770 intraday, closing Rs.758.35 (+1.76%)

May 29: Sharp decline of 16.67% to Rs.631.90 following Q4 FY26 results

Week Open

Rs.733.40

Wee...

Read full news article

Lincoln Pharmaceuticals Q4 FY26: Profit Stagnates Amid Margin Compression and Volatile Other Income

2026-05-29 10:04:22

Lincoln Pharmaceuticals Ltd., the Ahmedabad-based pharmaceutical formulations manufacturer, reported a marginal 0.43% year-on-year increase in net profit to ₹11.63 crores for Q4 FY26, barely surpassing the ₹11.58 crores posted in Q4 FY25. The muted earnings growth came despite an 11.36% rise in net sales to ₹187.28 crores, as the company grappled with contracting operating margins and a significant negative swing in other income. The stock plummeted 10.73% on May 29, 2026, closing at ₹677.00, reflecting investor disappointment with the lacklustre quarterly performance from a company valued at ₹1,356 crores.

Read full news article

Broad-Based Technical Strength Lifts Lincoln Pharmaceuticals Ltd to 52-Week High of Rs 770

2026-05-27 09:49:57

Surging to a fresh 52-week high of Rs 770 on 27 May 2026, Lincoln Pharmaceuticals Ltd has demonstrated robust price momentum, outperforming its sector and the broader market with a 37.3% gain over the past year against the Sensex’s decline of 6.9%.

Read full news article